Home » Authors » Mark McCarty

Articles by Mark McCarty

Reclassification attempt falls short on waveform reproduction

June 6, 2006

By Mark McCarty

Healthcare IT groups link up, hoping for more clout on Hill

June 2, 2006

By Mark McCarty

Clinical practice and critical coronary care

June 1, 2006

By Mark McCarty

FDA and CDRH, via MDII, keep up improvements drumbeat

June 1, 2006

By Mark McCarty

Radiological devices panel gives nod to FFDM reclassification

June 1, 2006

By Mark McCarty

GOP, Dems butt heads over privacy language of HIT bill

May 31, 2006

By Mark McCarty

FDA and CDRH, via MDII, keep up 'improvements' drumbeat

May 30, 2006

By Mark McCarty

Radiological devices panel gives nod to FFDM reclassification

May 25, 2006

By Mark McCarty

PMA stretch goals 'incompatible' with cycle and decision goals

May 24, 2006

By Mark McCarty

Heart Rhythm 2006: Prophylaxis, ethics drive higher U.S. implantation rates of ICDs

May 23, 2006

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 22, 2023.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 23, 2022.
Nasal spray Zavzpret cleared, Pfizer showing ‘growth on every measure’ in migraine
BioWorld
Pricing won’t be known until later for Pfizer Inc.’s Zavzpret (zavegepant), which became the first and only calcitonin gene-related peptide receptor antagonist...
AI drug discovery startup Protai raises $12M in seed funding
BioWorld
Artificial intelligence (AI)-powered drug discovery startup Protai Bio Ltd. raised $12 million in additional seed funding, bringing the total amount to $20...
Flagship puts $50M toward targeted tissue-homing tech startup
BioWorld
In an ideal world, when a patient takes a medicine, it acts only at the specific site of disease in the human body whilst sparing healthy tissues. But it almost...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.